Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
about
P2Y12 Receptor Modulates Sepsis-Induced InflammationEffects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridinesAntiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)
P2860
Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ticagrelor potentiates adenosi ...... il chemotaxis and phagocytosis
@en
type
label
Ticagrelor potentiates adenosi ...... il chemotaxis and phagocytosis
@en
prefLabel
Ticagrelor potentiates adenosi ...... il chemotaxis and phagocytosis
@en
P2093
P2860
P50
P1476
Ticagrelor potentiates adenosi ...... il chemotaxis and phagocytosis
@en
P2093
Haroon Khan
Heather M Judge
Mark R Thomas
Victoria C Ridger
P2860
P304
P356
10.1016/J.VPH.2015.02.006
P577
2015-04-11T00:00:00Z